Published in J Neurosci on March 15, 1998
The TTX-resistant sodium channel Nav1.8 (SNS/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons. J Physiol (2003) 2.59
Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron (2012) 2.11
Distinct potassium channels on pain-sensing neurons. Proc Natl Acad Sci U S A (2001) 1.90
Engagement of descending inhibition from the rostral ventromedial medulla protects against chronic neuropathic pain. Pain (2011) 1.82
Tetrodotoxin-resistant impulses in single nociceptor nerve terminals in guinea-pig cornea. J Physiol (1998) 1.76
A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc Natl Acad Sci U S A (1999) 1.66
Electrophysiological properties of sodium current subtypes in small cells from adult rat dorsal root ganglia. J Physiol (1998) 1.65
The tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. J Physiol (2003) 1.54
Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na(+) current and delayed rectifier K(+) current in rat sensory neurons. J Physiol (2002) 1.53
Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J Biol Chem (2004) 1.43
Afferent nerve regulation of bladder function in health and disease. Handb Exp Pharmacol (2009) 1.42
Single-cell analysis of sodium channel expression in dorsal root ganglion neurons. Mol Cell Neurosci (2010) 1.30
A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol (2004) 1.24
Pressure and stretch mechanosensitivity of peripheral nerve fibres following local inflammation of the nerve trunk. Pain (2005) 1.23
Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy. Mol Pain (2009) 1.19
Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes. Front Pharmacol (2011) 1.16
Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis. Proc Natl Acad Sci U S A (2000) 1.05
Tetrodotoxin-resistant voltage-dependent sodium channels in identified muscle afferent neurons. J Neurophysiol (2012) 1.01
Subthreshold oscillations induced by spinal nerve injury in dissociated muscle and cutaneous afferents of mouse DRG. J Neurophysiol (2002) 0.97
Hypermorphic mutation of the voltage-gated sodium channel encoding gene Scn10a causes a dramatic stimulus-dependent neurobehavioral phenotype. Proc Natl Acad Sci U S A (2011) 0.93
NaV1.8 channels are expressed in large, as well as small, diameter sensory afferent neurons. Channels (Austin) (2012) 0.93
Governing role of primary afferent drive in increased excitation of spinal nociceptive neurons in a model of sciatic neuropathy. Exp Neurol (2008) 0.92
Differing alterations of sodium currents in small dorsal root ganglion neurons after ganglion compression and peripheral nerve injury. Mol Pain (2008) 0.91
Sodium channel blockers for the treatment of neuropathic pain. Neurotherapeutics (2009) 0.91
Pain related channels are differentially expressed in neuronal and non-neuronal cells of glabrous skin of fabry knockout male mice. PLoS One (2014) 0.91
ATP-sensitive potassium currents reduce the PGE2-mediated enhancement of excitability in adult rat sensory neurons. Brain Res (2007) 0.90
Inactivation properties of sodium channel Nav1.8 maintain action potential amplitude in small DRG neurons in the context of depolarization. Mol Pain (2007) 0.90
Functional up-regulation of Nav1.8 sodium channel in Aβ afferent fibers subjected to chronic peripheral inflammation. J Neuroinflammation (2014) 0.88
Involvement of Nav 1.8 sodium ion channels in the transduction of mechanical pain in a rodent model of osteoarthritis. Arthritis Res Ther (2012) 0.87
Neurotrophin-3 significantly reduces sodium channel expression linked to neuropathic pain states. Exp Neurol (2008) 0.86
Alteration of primary afferent activity following inferior alveolar nerve transection in rats. Mol Pain (2010) 0.86
Transmembrane segments prevent surface expression of sodium channel Nav1.8 and promote calnexin-dependent channel degradation. J Biol Chem (2010) 0.86
Changes in osmolality modulate voltage-gated sodium channels in trigeminal ganglion neurons. Neurosci Res (2009) 0.85
Differential sensitivity to tetrodotoxin and lack of effect of prostaglandin E2 on the pharmacology and physiology of propagated action potentials. Br J Pharmacol (2002) 0.85
Relationship of axonal voltage-gated sodium channel 1.8 (NaV1.8) mRNA accumulation to sciatic nerve injury-induced painful neuropathy in rats. J Biol Chem (2011) 0.81
Reduced excitability of gp130-deficient nociceptors is associated with increased voltage-gated potassium currents and Kcna4 channel upregulation. Pflugers Arch (2014) 0.81
Alteration of the mu opioid receptor: Ca2+ channel signaling pathway in a subset of rat sensory neurons following chronic femoral artery occlusion. J Neurophysiol (2014) 0.81
The κ-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons. Reg Anesth Pain Med (2012) 0.81
Expression of DNA methyltransferases in adult dorsal root ganglia is cell-type specific and up regulated in a rodent model of neuropathic pain. Front Cell Neurosci (2014) 0.79
Antinociceptive activities of lidocaine and the nav1.8 blocker a803467 in diabetic rats. J Am Assoc Lab Anim Sci (2012) 0.78
Serotonergic transmission after spinal cord injury. J Neural Transm (Vienna) (2014) 0.78
Expression of activating transcription factor 3 (ATF3) in uninjured dorsal root ganglion neurons in a lower trunk avulsion pain model in rats. Eur Spine J (2013) 0.78
SCN10A Mutation in a Patient with Erythromelalgia Enhances C-Fiber Activity Dependent Slowing. PLoS One (2016) 0.77
Subarachnoid Transplant of the Human Neuronal hNT2.19 Serotonergic Cell Line Attenuates Behavioral Hypersensitivity without Affecting Motor Dysfunction after Severe Contusive Spinal Cord Injury. Neurol Res Int (2011) 0.77
Antihyperalgesic effects of ProTx-II, a Nav1.7 antagonist, and A803467, a Nav1.8 antagonist, in diabetic mice. J Exp Pharmacol (2015) 0.76
Distinct degree of radiculopathy at different levels of peripheral nerve injury. Mol Pain (2012) 0.75
Voltage-gated Na(+) channels in chemoreceptor afferent neurons--potential roles and changes with development. Respir Physiol Neurobiol (2012) 0.75
Ototrauma induces sodium channel plasticity in auditory afferent neurons. Mol Cell Neurosci (2011) 0.75
A New Regulatory Mechanism for Kv7.2 Protein During Neuropathy: Enhanced Transport from the Soma to Axonal Terminals of Injured Sensory Neurons. Front Cell Neurosci (2015) 0.75
Nomenclature of voltage-gated sodium channels. Neuron (2000) 3.10
Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis. Am J Surg (1988) 2.31
Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons. J Biol Chem (1996) 2.28
Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Br J Pharmacol (1997) 2.18
Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci U S A (1996) 2.10
A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J Biol Chem (1997) 1.91
Increased acid-sensing ion channel ASIC-3 in inflamed human intestine. Eur J Gastroenterol Hepatol (2001) 1.87
RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology (1997) 1.83
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci U S A (1990) 1.82
Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature. J Auton Pharmacol (1986) 1.79
Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain. Br J Pharmacol (1995) 1.71
A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc Natl Acad Sci U S A (1999) 1.66
Signet ring cell carcinoma in hyperplastic polyp. Scand J Gastroenterol (1995) 1.60
Angiogenic factor. Nature (1992) 1.59
The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Br J Pharmacol (1995) 1.57
Electrophysiological and antiarrhythmic effects of the atrial selective 5-HT(4) receptor antagonist RS-100302 in experimental atrial flutter and fibrillation. Circulation (1999) 1.54
Angiogenic activity of enzymes. Nature (1994) 1.44
Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3. Mol Pharmacol (1995) 1.42
The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol (1995) 1.41
Surgical management of patients with radiation enteritis. Int Surg (1997) 1.40
Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol (1997) 1.39
Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder. Life Sci (1999) 1.33
Peripheral 5-HT4 receptors. FASEB J (1996) 1.32
Some physical and chemical properties of the smooth muscle inhibitory factor in extracts of the bovine retractor penis muscle. J Physiol (1981) 1.30
Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. Br J Pharmacol (1997) 1.29
The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology (Berl) (1996) 1.27
Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding. Biochem Pharmacol (1998) 1.26
The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol (1997) 1.26
Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res (1995) 1.25
Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury. Pain (1999) 1.25
Action of agonists and antagonists at muscarinic receptors present on ileum and atria in vitro. Br J Pharmacol (1985) 1.24
Rhabdomyolysis of the upper extremities associated with weight lifting: report of a case. J Am Osteopath Assoc (1985) 1.24
Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol. J Pharmacol Exp Ther (1990) 1.23
5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine-induced desensitization as a discriminative tool for the 5-HT3 and putative 5-HT4 receptors in guinea pig ileum. Naunyn Schmiedebergs Arch Pharmacol (1990) 1.20
5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. Br J Pharmacol (1995) 1.18
Functional analysis of a voltage-gated sodium channel and its splice variant from rat dorsal root ganglia. J Neurochem (1998) 1.17
Effect of dopamine agonists and antagonists on ethanol-reinforced behavior: the involvement of the nucleus accumbens. Brain Res Bull (1993) 1.16
An immunochemical analysis of the distribution of a brain-specific polypeptide, PEP-19. J Neurochem (1988) 1.16
Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b). Br J Pharmacol (1997) 1.15
Characterization of prostanoid receptor-evoked responses in rat sensory neurones. Br J Pharmacol (1998) 1.15
Pharmacological characterization of muscarinic receptors in rabbit isolated iris sphincter muscle and urinary bladder smooth muscle. Br J Pharmacol (1998) 1.14
Competitive and non-competitive antagonism exhibited by 'selective' antagonists at atrial and ileal muscarinic receptor subtypes. Br J Pharmacol (1987) 1.13
Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Int J Cancer (1997) 1.12
Cerebellar Purkinje cell markers are expressed in retinal bipolar neurons. J Comp Neurol (1991) 1.11
The involvement of the tetrodotoxin-resistant sodium channel Na(v)1.8 (PN3/SNS) in a rat model of visceral pain. J Neurosci (2001) 1.11
Ventral tegmental microinjections of quinpirole decrease ethanol and sucrose-reinforced responding. Alcohol Clin Exp Res (1993) 1.11
Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br J Cancer (1997) 1.10
Motility related protein 1 (MRP1/CD9) expression in colon cancer. Clin Cancer Res (1998) 1.10
The role of IP prostanoid receptors in inflammatory pain. Trends Pharmacol Sci (1998) 1.09
Complex gangliosides are essential in spermatogenesis of mice: possible roles in the transport of testosterone. Proc Natl Acad Sci U S A (1998) 1.09
Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum. Eur J Pharmacol (1995) 1.07
A tetrodotoxin-resistant voltage-gated sodium channel from human dorsal root ganglia, hPN3/SCN10A. Pain (1998) 1.07
Isolation, sequence, and developmental profile of a brain-specific polypeptide, PEP-19. Proc Natl Acad Sci U S A (1986) 1.07
Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. J Pharmacol Exp Ther (1999) 1.06
Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy. J Clin Invest (1995) 1.05
Identification of extracapsular invasion of the metastatic lymph nodes as a useful prognostic sign in patients with resectable colorectal cancer. Dis Colon Rectum (2001) 1.05
In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists. Br J Pharmacol (1999) 1.05
Clinicopathological features of mucosal carcinoma of the stomach with lymph node metastasis in eleven patients. Br J Surg (1986) 1.04
MRI in acute knee dislocation. A prospective study of clinical, MRI, and surgical findings. J Bone Joint Surg Br (1996) 1.04
Self-monitoring of blood glucose in diabetic pregnancy. Br Med J (1979) 1.03
7TM receptors: the splicing on the cake. Trends Pharmacol Sci (1999) 1.03
SNS/PN3 and SNS2/NaN sodium channel-like immunoreactivity in human adult and neonate injured sensory nerves. FEBS Lett (2000) 1.02
Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery (1991) 1.02
Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor. Biochim Biophys Acta (1995) 1.01
Differential distribution of the tetrodotoxin-sensitive rPN4/NaCh6/Scn8a sodium channel in the nervous system. J Neurosci Res (2000) 1.01
Prognostic factors in adenocarcinoma in the upper one-third of the stomach. Surg Gynecol Obstet (1991) 1.01
Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J (1996) 1.01
5-Hydroxytryptamine stimulates cyclic AMP formation in the tunica muscularis mucosae of the rat oesophagus via 5-HT4 receptors. Eur J Pharmacol (1992) 1.01
Computed tomography evaluation of fatty tumors of the somatic soft tissues: clinical utility and radiologic-pathologic correlation. Skeletal Radiol (1979) 1.00
Rationally designed "dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties. J Med Chem (1991) 1.00
MR imaging of rotator cuff tears in individuals with paraplegia. AJR Am J Roentgenol (1997) 1.00
QX-314 inhibits ectopic nerve activity associated with neuropathic pain. Brain Res (1997) 0.99
RS 39604: a potent, selective and orally active 5-HT4 receptor antagonist. Br J Pharmacol (1995) 0.99
Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biochem (1993) 0.99
Pharmacological characterization of muscarinic receptors in mouse isolated urinary bladder smooth muscle. Br J Pharmacol (2001) 0.99
Expression of MAGE genes in human colorectal carcinoma. Ann Surg (1996) 0.98
Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms. FEBS Lett (1998) 0.97
Characterization of putative 5-ht7 receptors mediating direct relaxation in Cynomolgus monkey isolated jugular vein. Br J Pharmacol (1996) 0.97
Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding. Br J Pharmacol (1991) 0.97
Tetrodotoxin inhibits neuropathic ectopic activity in neuromas, dorsal root ganglia and dorsal horn neurons. Pain (1997) 0.97
RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist. Br J Pharmacol (1999) 0.97
DNA ploidy and tumor invasion in human gastric cancer. Histopathologic differentiation. Arch Surg (1989) 0.96
Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats. Pain (1999) 0.96